Odonate Therapeutics, Inc.
ODTC
Revenue
0.00
0.000.00%
-Assets
105.77M
▼-12.80M▼-10.80%
3 Months ChangeLiabilities
34.40M
▲454.00k▲1.34%
3 Months ChangeFree Cash Flow
-24.93M
▲2.93M▲10.53%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2022-01-07
Form 8-K
ID: 0001564590-22-000598
2021-11-18
Form 8-K
ID: 0001564590-21-057650
2021-11-10
Form 10-Q
ID: 0001564590-21-056269
2021-08-05
Form 8-K
ID: 0001564590-21-041643
2021-07-27
Form 10-Q
ID: 0001564590-21-038065
2021-06-25
Form 8-K
ID: 0001564590-21-034592
2021-05-14
Form 10-Q
ID: 0001564590-21-027812
2021-03-25
Form 8-K
ID: 0001564590-21-015499
2021-02-23
Form 8-K
ID: 0001564590-21-007307
2020-12-15
Form 8-K
ID: 0001564590-20-057158